Baicalin relieves neuropathic pain by regulating α2‑adrenoceptor levels in rats following spinal nerve injury

Huang,Lan‑Ji; Jia,Shu‑Shan; Sun,Xue‑Hua; Li,Xin‑You; Wang,Fei‑Fei; Li,Wei; Jin,Qing‑Song

doi:10.3892/etm.2020.9019

Baicalin relieves neuropathic pain by regulating α2‑adrenoceptor levels in rats following spinal nerve injury

Authors:
- Lan‑Ji Huang
- Shu‑Shan Jia
- Xue‑Hua Sun
- Xin‑You Li
- Fei‑Fei Wang
- Wei Li
- Qing‑Song Jin
View Affiliations

Affiliations: Department of Anesthesiology, Yantai Affiliated Hospital of Binzhou Medical University, Yantai, Shandong 264100, P.R. China, Department of Endocrinology, Yantai Affiliated Hospital of Binzhou Medical University, Yantai, Shandong 264100, P.R. China
Published online on: July 17, 2020 https://doi.org/10.3892/etm.2020.9019
Pages: 2684-2690
Copyright: © Huang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

In the present study, the ability of baicalin to relieve neuropathic pain due to spinal nerve ligation in rats was explored, and the relationship between baicalin and α2‑adrenoceptors (α2‑AR) was determined. The neuropathic pain model was established by ligating the L5‑L6 spinal nerves in Sprague‑Dawley rats. Several α2‑AR antagonists were injected into the intramedullary sheath to evaluate the role of baicalin in neuropathic pain. The antagonists included nonselective α2‑AR antagonist idazoxan, α2a‑AR antagonist BRL 44408, α2b‑AR antagonist ARC 239 and α2c‑AR antagonist JP 1302. The rats were divided into an untreated control group, saline group, baicalin group and baicalin + α2‑AR antagonist groups. Paw withdrawal threshold (PWT) was tested to assess the level of pain felt by the rats. The levels of α2‑AR mRNA were tested by reverse transcription‑quantitative PCR. Inflammatory factors, including tumor necrosis factor (TNF)‑α, interleukin (IL)‑6, IL‑17 and IL‑1β, were analyzed by ELISA. The histopathological changes were assessed by hematoxylin and eosin staining. Flow cytometry was used to examine the percentage of CD4+ peripheral blood mononuclear cells (PBMCs). Compared with the saline group, the PWT value increased after treating with baicalin. However, intrathecal injection of α2‑AR antagonist reversed the antinociceptive effects of baicalin. Compared with the saline group, the expression of α2a‑AR and α2c‑AR mRNA was upregulated significantly in the baicalin group (P<0.05). Levels of α2‑AR mRNA were also decreased in the baicalin + idazoxan group compared with the baicalin group (P<0.05). The levels of TNF‑α, IL‑6, IL‑17 and IL‑1β were raised after treatment with baicalin. In addition, baicalin treatment ameliorated the histological damage in the spinal cord. The percentage of CD4+ PBMCs was increased in the saline group compared with the control group (P<0.05). Compared with the baicalin group, the percentage of CD4+ PBMCs was raised after treatment with the α2‑AR antagonists. In conclusion, intrathecal injection of baicalin produced an antiallodynic effect in a spinal nerve ligation‑induced neuropathic pain model. The mechanism may be related to the regulation of a2‑AR expression.

View Figures

View References

1	Zhao Y, Xin Y and Chu H: MC4R is involved in neuropathic pain by regulating JNK signaling pathway after chronic constriction injury. Front Neurosci. 13(919)2019.PubMed/NCBI View Article : Google Scholar
2	Matias Júnior I, Medeiros P, de Freita RL, Vicente-César H, Ferreira Junior JR, Machado HR and Menezes-Reis R: Effective parameters for gait analysis in experimental models for evaluating peripheral nerve injuries in rats. Neurospine. 16:305–316. 2019.PubMed/NCBI View Article : Google Scholar
3	Yao C, Zhou X, Zhao B, Sun C, Poonit K and Yan H: Treatments of traumatic neuropathic pain: A systematic review. Oncotarget. 8:57670–57679. 2017.PubMed/NCBI View Article : Google Scholar
4	Taheri A, Lajevardi M, Emami S, Shabani S and Sharifi H: Commentary: Non-invasive brain stimulation, a tool to revert maladaptive plasticity in neuropathic pain. Front Hum Neurosci. 11(172)2017.PubMed/NCBI View Article : Google Scholar
5	Mankowski C, Poole CD, Ernault E, Thomas R, Berni E, Currie CJ, Treadwell C, Calvo JI, Plastira C, Zafeiropoulou E and Odeyemi I: Effectiveness of the capsaicin 8% patch in the management of peripheral neuropathic pain in european clinical practice: The ASCEND study. BMC Neurol. 17(80)2017.PubMed/NCBI View Article : Google Scholar
6	D'Arcy Y, McCarberg B, Parsons B, Behar R, Thorpe A and Alexander A: Pregabalin for the treatment of neuropathic pain: A narrative review for primary care providers. Curr Med Res Opin. 33:1353–1359. 2017.PubMed/NCBI View Article : Google Scholar
7	Wang YX, Mao XF, Li TF, Gong N and Zhang MZ: Dezocine exhibits antihypersensitivity activities in neuropathy through spinal µ-opioid receptor activation and norepinephrine reuptake inhibition. Sci Rep. 7(43137)2017.PubMed/NCBI View Article : Google Scholar
8	Di Cesare Mannelli L, Micheli L, Crocetti L, Giovannoni MP, Vergelli C and Ghelardini C: α2 adrenoceptor: A target for neuropathic pain treatment. Mini Rev Med Chem. 17:95–107. 2017.PubMed/NCBI View Article : Google Scholar
9	Li C, Ji BU, Kim Y, Lee JE, Kim NK, Kim ST and Koo S: Electroacupuncture enhances the antiallodynic and antihyperalgesic effects of milnacipran in neuropathic rats. Anesth Analg. 122:1654–1662. 2016.PubMed/NCBI View Article : Google Scholar
10	Romero-Sandoval EA, McCall C and Eisenach JC: Alpha2-adrenoceptor stimulation transforms immune responses in neuritis and blocks neuritis-induced pain. J Neurosci. 25:8988–8994. 2005.PubMed/NCBI View Article : Google Scholar
11	Chabot-Doré AJ, Millecamps M, Naso L, Devost D, Trieu P, Piltonen M, Diatchenko L, Fairbanks CA, Wilcox GL, Hébert TE and Stone LS: Dual allosteric modulation of opioid antinociceptive potency by α2A-adrenoceptors. Neuropharmacology. 99:285–300. 2015.PubMed/NCBI View Article : Google Scholar
12	Hughes S, Hickey L, Donaldson LF, Lumb BM and Pickering AE: Intrathecal reboxetine suppresses evoked and ongoingneuropathic pain behaviours by restoring spinal noradrenergic inhibitory tone. Pain. 156:328–334. 2015.PubMed/NCBI View Article : Google Scholar
13	Lin CC and Shieh DE: The anti-inflammatory activity of scutellaria rivularis extracts and its active components, baicalin, baicalein and wogonin. Am J Chin Med. 24:31–36. 1996.PubMed/NCBI View Article : Google Scholar
14	Boadas-Vaello P, Vela JM and Verdu E: New pharmacological approaches using polyphenols on the physiopathology of neuropathic pain. Curr Drug Targets. 18:160–173. 2017.PubMed/NCBI View Article : Google Scholar
15	Cherng CH, Lee KC, Chien CC, Chou KY, Cheng YC, Hsin ST, Lee SO, Shen CH, Tsai RY and Wong CS: Baicalin ameliorates neuropathic pain by suppressing HDAC1 expression in the spinal cord of spinal nerve ligation rats. J Formos Med Assoc. 113:513–520. 2014.PubMed/NCBI View Article : Google Scholar
16	Chou TC, Chang LP, Li CY, Wong CS and Yang SP: The antiinflammatory and analgesic effects of baicalin in carrageenan-evoked thermal hyperalgesia. Anesth Analg. 97:1724–1729. 2003.PubMed/NCBI View Article : Google Scholar
17	Levy RM, Saikovsky R, Shmidt E, Khokhlov A and Burnett BP: Flavocoxid is as effective as naproxen for managing the signs and symptoms of osteoarthritis of the knee in humans: A short-term randomized, double-blind pilot study. Nutr Res. 29:298–304. 2009.PubMed/NCBI View Article : Google Scholar
18	Chaplan SR, Bach FW, Pogrel JW, Chung JM and Yaksh TL: Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods. 53:55–63. 1994.PubMed/NCBI View Article : Google Scholar
19	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C (T)) method. Methods. 25:402–408. 2001.PubMed/NCBI View Article : Google Scholar
20	Listowska M, Glac W, Grembecka B, Grzybowska M and Wrona D: Changes in blood CD4⁺T and CD8⁺T lymphocytes in stressed rats pretreated chronically with desipramine are more pronounced after chronic open field stress challenge. J Neuroimmunol. 282:54–62. 2015.PubMed/NCBI View Article : Google Scholar
21	Xue ZJ, Shen L, Wang ZY, Hui SY, Huang YG and Ma C: STAT3 inhibitor WP1066 as a novel therapeutic agent for bCCI neuropathic pain rats. Brain Res. 1583:79–88. 2014.PubMed/NCBI View Article : Google Scholar
22	Li X and Eisenach JC: alpha2A-adrenoceptor stimulation reduces capsaicin-induced glutamate release from spinal cord synaptosomes. J Pharmacol Exp Ther. 299:939–944. 2001.PubMed/NCBI
23	Donello JE, Guan Y, Tian M, Cheevers CV, Alcantara M, Cabrera S, Raja SN and Gil DW: A peripheral adrenoceptor-mediated sympathetic mechanism can transform stress-induced analgesia into hyperalgesia. Anesthesiology. 114:1403–1416. 2011.PubMed/NCBI View Article : Google Scholar
24	Hayashida K, Kimura M, Yoshizumi M, Hobo S, Obata H and Eisenach JC: Ondansetron reverses anti-hypersensitivity from clonidine in rats following peripheral nerver injury: Role of γ-amino butyric acid in α2-adrenoceptor and 5-HT3 serotonin receptor analgesia. Anesthesiolgy. 117:389–398. 2012.PubMed/NCBI View Article : Google Scholar
25	Hayashida K and Eisenach JC: Spinal alpha 2-adrenoceptor- mediated analgesia in neuropathic pain reflects brain-derived nerve growth factor and changes in spinal cholinergic neuronal function. Anesthesiology. 113:406–412. 2010.PubMed/NCBI View Article : Google Scholar
26	Kiasalari Z, Rahmani T, Mahmoudi N, Baluchnejadmojarad T and Roghani M: Diosgenin ameliorates development of neuropathic pain in diabetic rats: Involvement of oxidative stress and inflammation. Biomed Pharmacother. 86:654–661. 2017.PubMed/NCBI View Article : Google Scholar
27	Ghasemzadeh RM, Amin B, Mehri S, Mirnajafi-Zadeh SJ and Hosseinzadeh H: Anti-inflammatory effects of ethanolic extract of rosmarinus officinalis L. and rosmarinic acid in a rat model of neuropathic pain. Biomed Pharmacother. 86:441–449. 2017.PubMed/NCBI View Article : Google Scholar